#335 – Thomas Eiden, Atomic Alchemy - There Is A Vast Shortage Of Man Made Radioactive Materials

<p class="p1">In episode 335, we welcome our guest, Thomas Eiden, founder of Atomic Alchemy, a company dedicated to producing radioisotopes used in nuclear medicine.</p> <p class="p2"> </p> <p class="p2"> </p> <p class="p1">In today’s episode, we’re going nuclear! Thomas is undertaking the audacious goal of building a nuclear reactor, something that takes almost a decade and roughly 100 million dollars. We start with what sparked his interest in nuclear energy and what gave him the nudge to apply to Y Combinator and raise seed capital with just a business plan. We take some time to dispel myths around why nuclear energy is dangerous and then pivot to talk about the uses in the medical field, whether it’s with MRI’s or trying to fight cancer.<span class= "Apple-converted-space"> </span></p> <p class="p2"> </p> <p class="p2"> </p> <p class="p1">Please enjoy this episode with Atomic Alchemy’s Thomas Eiden.     </p> <p class="p2"> </p> <p class="p2"> </p> <p class="p1">-----</p> <p class="p2"> </p> <p class="p2"> </p> <p style="font-weight: 400;">Follow Meb on <a href= "https://twitter.com/MebFaber">Twitter</a>, <a href= "https://www.linkedin.com/in/mebanefaber/">LinkedIn</a> and <a href="https://www.youtube.com/channel/UCKvWzzrVUA_DSCoKXL6GU2w">YouTube</a></p> <p style="font-weight: 400;">For detailed show notes, click <a href="https://mebfaber.com/2021/07/30/e335-thomas-eiden/">here</a></p> <p style="font-weight: 400;">To learn more about our products and follow us, subscribe to our <a href= "https://theideafarm.us1.list-manage.com/subscribe/post?u=6750faf5c6091bc898da154ff&id=7249739cdb"> mailing list</a> or visit us at <a href= "cambriainvestments.com">cambriainvestments.com.</a></p> <p class="p2"> </p> <p class="p2"> </p> <p class="p1">-----</p> <p class="p1"> </p> <p class="p1"> </p> <p class="p1">Today’s episode is sponsored by <a href= "https://theideafarm.com/"><span class="s1">The Idea Farm</span></a>. The Idea Farm gives you access to over $100,000 worth of investing research, the kind usually read by only